NEW YORK (GenomeWeb News) – Silicon Valley Biosystems, a company that provides genomic data at the point of care, has been launched.

The Foster City, Calif.-based firm was launched today with financial backing from venture capital firm Sequoia Capital to provide turnkey genomics interpretation services to clinicians "to make faster, more precise, and cost-saving decisions," according to SV Bio.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.